BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 6395836)

  • 1. [Morphological criteria of the malignancy of pheochromocytoma].
    Cheremnykh AA; Kalashnikov SA
    Arkh Patol; 1984; 46(12):30-6. PubMed ID: 6395836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [About the signs of malignant pheochromocytoma].
    Simonenko VB; Makanin MA; Dulin PA; Vasilchenko MI; Lesovik VS
    Klin Med (Mosk); 2012; 90(10):64-8. PubMed ID: 23285767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic significance of the morphological signs of the malignancy of a pheochromocytoma].
    Kalashnikov SA; Trofimova VM; Veresova AA
    Vopr Onkol; 1979; 25(6):47-51. PubMed ID: 462872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pheochromocytoma--pathohistologic and immunohistochemical aspects].
    Tatić S; Havelka M; Paunović I; Bozić V; Diklic A; Brasanac D; Janković R; Jancić-Zguricas M
    Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():7-13. PubMed ID: 12584991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostic guidelines for adrenal gland nodules: typing, assessment of biological potential and prognosis, molecular pathogenesis].
    Schröder S; Padberg B; Reincke M; Komminoth P
    Verh Dtsch Ges Pathol; 1997; 81():97-102. PubMed ID: 9474859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic concept in incidentaloma of the adrenal gland].
    Waldner H; Wilker D; Izbicki J; Kenn R
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():995-7. PubMed ID: 1983695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benign and malignant pheochromocytoma: diagnosis, treatment, and follow-Up.
    Kebebew E; Duh QY
    Surg Oncol Clin N Am; 1998 Oct; 7(4):765-89. PubMed ID: 9735133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignancy in pheochromocytomas.
    Salmenkivi K; Heikkilä P; Haglund C; Arola J
    APMIS; 2004 Sep; 112(9):551-9. PubMed ID: 15601303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic management of benign and malignant pheochromocytoma.
    Scholz T; Schulz C; Klose S; Lehnert H
    Exp Clin Endocrinol Diabetes; 2007 Mar; 115(3):155-9. PubMed ID: 17427102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Personal experience in diagnosis and localization of pheochromocytoma].
    Andjelković Z; Tavcar I
    Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():14-9. PubMed ID: 12584992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonsporadic cases and unusual morphological features in pheochromocytoma and paraganglioma.
    Lamovec J; Frković-Grazio S; Bracko M
    Arch Pathol Lab Med; 1998 Jan; 122(1):63-8. PubMed ID: 9448019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Malignant pheochromocytoma. A case report and comments on a rare pathology].
    Boneschi M; Erba M; Rinaldi P; Cusmai F; Miani S
    Minerva Chir; 1999; 54(1-2):73-8. PubMed ID: 10230231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pheochromocytomas as adrenal gland incidentalomas].
    Cerović S; Cizmić M; Milović N; Ajdinović B; Brajusković G
    Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():47-51. PubMed ID: 12584998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remarkably suppressed manganese superoxide dismutase activity in malignant pheochromocytoma.
    Nakada T; Kubota Y; Sasagawa I; Yagisawa T; Watanabe M; Ishigooka M
    J Urol; 1995 Jun; 153(6):1787-90. PubMed ID: 7752317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting metastasis of pheochromocytomas using DNA flow cytometry and immunohistochemical markers of cell proliferation: A positive correlation between MIB-1 staining and malignant tumor behavior.
    Brown HM; Komorowski RA; Wilson SD; Demeure MJ; Zhu YR
    Cancer; 1999 Oct; 86(8):1583-9. PubMed ID: 10526289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pheochromocytoma and the diagnosis of malignancy: recent data and the role of the pathologist].
    Patey M
    Ann Pathol; 2008 Nov; 28 Spec No 1(1):S42-4. PubMed ID: 18984296
    [No Abstract]   [Full Text] [Related]  

  • 17. Oncologic aspects of pheochromocytoma: the importance of follow-up.
    Scott HW; Halter SA
    Surgery; 1984 Dec; 96(6):1061-6. PubMed ID: 6505959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expansive adrenal pathology: clinico-diagnostic considerations of 19 surgically treated cases].
    Maniscalco L; Morosini PP; Sabbatini A; Campanella N; Landa L; Marcolini P
    Chir Patol Sper; 1982 Oct; 30(5):169-79. PubMed ID: 7187891
    [No Abstract]   [Full Text] [Related]  

  • 19. Should pheochromocytoma size influence surgical approach? A comparison of 90 malignant and 60 benign pheochromocytomas.
    Shen WT; Sturgeon C; Clark OH; Duh QY; Kebebew E
    Surgery; 2004 Dec; 136(6):1129-37. PubMed ID: 15657566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and pathological data of 10 malignant pheochromocytomas: long-term follow up in a single institute.
    Huang KH; Chung SD; Chen SC; Chueh SC; Pu YS; Lai MK; Lin WC
    Int J Urol; 2007 Mar; 14(3):181-5. PubMed ID: 17430251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.